Validación y aplicación clínica de MammaPrint ® en pacientes con cáncer de mama | Zendy

Ernesto Roberto Sánchez-Forgach | Zendy; Ubaldo Carpinteyro-Espín | Zendy; Jorge Alberto Alemán-Áviles | Zendy; Carlos Sánchez-Basurto | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Validación y aplicación clínica de MammaPrint ® en pacientes con cáncer de mama

Author(s) -

Ernesto Roberto Sánchez-Forgach,

Ubaldo Carpinteyro-Espín,

Jorge Alberto Alemán-Áviles,

Carlos Sánchez-Basurto

Publication year - 2016

Publication title -

cirugía y cirujanos

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.139

H-Index - 16

eISSN - 2444-054X

pISSN - 0009-7411

DOI - 10.1016/j.circir.2016.10.019

Subject(s) - medicine , breast cancer , gynecology , humanities , cancer , philosophy

In recent years, advances in molecular biology have resulted in innovations in breast cancer diagnostics and therapeutics. The development of genomics has revolutionized our understanding of this disease. MammaPrin ® was developed as a diagnostic tool to predict risk of breast cancer recurrence using the expression of 70 genes altering the clinicopathologic paradigm of selection of patients for adjuvant cytotoxic chemotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research